Skopos Labs, Inc. Incyte Corp Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Skopos Labs, Inc. holds 1,137 shares of INCY stock, worth $73,973. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,137
Previous 482
135.89%
Holding current value
$73,973
Previous $33,000
106.06%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding INCY
# of Institutions
695Shares Held
194MCall Options Held
564KPut Options Held
331K-
Baker Bros. Advisors LP New York, NY30.7MShares$2 Billion22.18% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.39 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$1.3 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$967 Million0.55% of portfolio
-
State Street Corp Boston, MA10MShares$653 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $14.5B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...